Rocket Pharmaceuticals is a biotech company striving to develop gene therapies for rare diseases. With four clinical-stage programs, the company is targeting Fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease. Rocket Pharmaceuticals has partnerships with various research centers and institutions and is headquartered in New Jersey.